Effects of Verapamil on Ventricular Wall Thickness of Patients with Hypertrophic Cardiomyopathy

1982 ◽  
pp. 203-213
Author(s):  
Heinz O. Hirzel ◽  
Michel P. Troesch ◽  
Rolf Jenni ◽  
Hans P. Krayenbuehl
1988 ◽  
Vol 2 (3) ◽  
pp. 134-139 ◽  
Author(s):  
J. Candell-Riera ◽  
A. Alvarez-Auñón ◽  
F. Balda-Caravedo ◽  
H. Garcia-del-Castillo ◽  
G. Permanyer-Miralda ◽  
...  

Cardiology ◽  
2015 ◽  
Vol 133 (1) ◽  
pp. 35-43 ◽  
Author(s):  
Xiying Guo ◽  
Chaomei Fan ◽  
Hongyue Wang ◽  
Shihua Zhao ◽  
Fujian Duan ◽  
...  

Objectives: Extreme left ventricular hypertrophy (LVH) is a known risk factor for sudden cardiac death in hypertrophic cardiomyopathy (HCM). Extreme right ventricular hypertrophy (RVH) is rare, and whether it is linked to a poor outcome is unknown. This study was designed to investigate differences between HCM patients with extreme RVH and those with extreme LVH. Methods: Among 2,413 HCM patients, 31 with extreme RVH (maximum right ventricular wall thickness ≥10 mm) and 194 with extreme LVH (maximum left ventricular wall thickness ≥30 mm) were investigated. The main clinical features and natural history were compared between the 2 groups. Results: The prevalence of extreme RVH and extreme LVH was 1.3 and 8.0%, respectively. Patients with extreme RVH tended to be younger and female (p < 0.01). Cardiovascular-related mortality and morbidity within 10 years were significantly greater in the extreme RVH group (p < 0.05). Multivariate analysis demonstrated 3 independent predictors for cardiovascular mortality - extreme RVH, left ventricular end-diastolic dimension ≥50 mm, and age ≤18 years at baseline - and 2 for morbidity - extreme RVH and presyncope. Conclusions: Compared with extreme LVH, extreme RVH was quite uncommon in HCM and had a worse prognosis. A right ventricle examination should be performed in routine HCM evaluation.


Sign in / Sign up

Export Citation Format

Share Document